Clinical Trials Browser

Unknown × Bone Diseases, Metabolic × Clear all

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

NCT03518268 2019-01-17

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Phase 1/2 Unknown

40 enrolled

Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT01105923 2015-02-02

MAPLE

Phase NA Unknown

140 enrolled

BreastClassical hematologyHead & Neck

Anemia, Sickle Cell, Asthma, Attention Deficit Disorder with Hyperactivity, Bone Diseases, Metabolic, Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Glaucoma, Heart Failure, Hemophilia A, Hypertension, Hyperthyroidism, Hypothyroidism, Myasthenia Gravis, Osteoporosis, Stroke, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

NCT00228124 2006-01-26

PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition

Unknown

300 enrolled

Genitourinary

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms

Clinical Trials

Intervention Study of Drugs in Patients Osteopenia and Osteoporosis

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

MAPLE

PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition